![Peter Lebowitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Lebowitz
Corporate Officer/Principal bei Janssen Research & Development LLC
Aktive Positionen von Peter Lebowitz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Janssen Research & Development LLC
![]() Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - | - |
Karriereverlauf von Peter Lebowitz
Ehemalige bekannte Positionen von Peter Lebowitz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aragon Pharmaceuticals, Inc.
![]() Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Janssen Research & Development LLC
![]() Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Aragon Pharmaceuticals, Inc.
![]() Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Peter Lebowitz
- Erfahrung